MedTrace Logo

A Study on the Effect of High-Calorie Infant Formula on Growth and Nutrition in HIV-Infected Infants

NCT00000873 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2400

Last updated 2013-10-07

No results posted yet for this study

Summary

This study examines the effects of an infant formula containing increased calories, as compared to commercial formulas, when given during the first 6 months of life. It will examine effects on growth, disease progress, immune system, and quality of life of infected infants.

HIV disease in infants often leads to nutritional deficiencies. Providing increased nutrition early in their lives may help the quality of life of children who contract HIV from their mothers.

Conditions

  • HIV Infections

Interventions

DRUG

Infant Formula

Sponsors & Collaborators

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    collaborator NIH

  • National Institute of Allergy and Infectious Diseases (NIAID)

    lead NIH

Principal Investigators

  • Harland S Winter

  • James Oleske

  • Ross McKinney

Study Design

Purpose
TREATMENT
Model
PARALLEL

Eligibility

Min Age
1 Day
Max Age
17 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Completion
2005-09-30

Countries

  • United States
  • Brazil
  • Puerto Rico
  • The Bahamas

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00000873 on ClinicalTrials.gov